Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
LEGN - Legend Biotech Corp
-0.90(-1.64%)6:00:00 PM 11/26/2021
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel cell therapies for oncology and other indications. Its lead product candidate, LCAR-B38M/JNJ-4528, is an autologous CAR-T cell therapy that targets the B-cell maturation antigen. The company is conducting multiple clinical trials to evaluate LCAR-B38M/JNJ-4528 as an earlier line of therapy for multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in Revlimid-refractory MM. It also has a broad portfolio of earlier-stage autologous product candidates targeting various cancers, including non-hodgkins lymphoma (NHL), acute myeloid leukemia, and T cell lymphoma. In addition, the company is developing an allogeneic CAR-T product candidate targeting CD20 for the treatment of NHL, which is currently in an investigator-initiated Phase 1 clinical trial in China. Further, it has various product candidates in early preclinical and clinical development for the treatment of solid tumors, as well as infectious diseases. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.


  • MACD is crossing MACD signal line at 0.4. MACD crossing signal line is bullish signal.
Stock Statistics
PE Ratio
PEG Ratio
P/S (ttm)65.0
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %0%
Held by Institutions %20%
1 Day Vol Adjusted Return-0.5
1 Month Vol Adjusted Return1.5
3 Month Vol Adjusted Return13.4
6 Month Vol Adjusted Return11.8
20 Days SMA Price ZScore1.0
50 Days SMA Price ZScore1.0
12 -26 Days PPO2.0
1 Month Average Short Volume Ratio42.6
1 Day Volume Change ZScore0.3
1 Month Daily Vol3.0
Related Topics
leak data

Related Topics


Related Peers

Stock news